New tri-glycyl peptide linker offers advantages for maytansinoid antibody-drug conjugates (ADCs).Rajeeva Singh,Nathan Fishkin,Yelena Kovtun,Gregory Jones,Jose Ponte,Hans Erickson,Erica Hong,Yulius Setiady, Andre Dandeneau,Katharine Lai,Jennifer Coccia,Leanne Lanieri, Juliet Bouchard,Karen Veale,Ravi Chari,Wayne WiddisonMOLECULAR CANCER THERAPEUTICS(2013)引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要